Steven W. King
2017
In 2017, Steven W. King earned a total compensation of $1.1M as Former President and Chief Executive Officer at Peregrine Pharmaceuticals, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $281,941 |
|---|---|
| Option Awards | $209,500 |
| Salary | $540,000 |
| Other | $51,365 |
| Total | $1,082,806 |
King received $540K in salary, accounting for 50% of the total pay in 2017.
King also received $281.9K in non-equity incentive plan, $209.5K in option awards and $51.4K in other compensation.
Rankings
In 2017, Steven W. King's compensation ranked 8,609th out of 14,666 executives tracked by ExecPay. In other words, King earned more than 41.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,609 out of 14,666 | 41st |
Division Manufacturing | 3,270 out of 5,772 | 43rd |
Major group Chemicals And Allied Products | 1,096 out of 2,075 | 47th |
Industry group Drugs | 869 out of 1,731 | 50th |
Industry Pharmaceutical Preparations | 680 out of 1,333 | 49th |
Source: SEC filing on August 17, 2018.
King's colleagues
We found three more compensation records of executives who worked with Steven W. King at Peregrine Pharmaceuticals in 2017.